Prospective controlled study comparing patient-reported outcomes after daily online adaptive radiotherapy or conventional IGRT in patients with prostate cancer
Year: 2025
Type: article
Language: en
Topic: Prostate Cancer Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Goda Kalinauskaite
raw_affiliation_strings: Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353 Berlin, Germany
German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site Berlin 10117 Berlin, Germany
National Center of Tumor Diseases (NCT), Heidelberg, Germany
raw_author_name: Luise A. Künzel
raw_affiliation_strings: Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353 Berlin, Germany
German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site Berlin 10117 Berlin, Germany
National Center of Tumor Diseases (NCT), Heidelberg, Germany
raw_author_name: Kerstin Rubarth
raw_affiliation_strings: Charité Universitätsmedizin - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Charitéplatz 1, 10117 Berlin, Germany
German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site Berlin 10117 Berlin, Germany
National Center of Tumor Diseases (NCT), Heidelberg, Germany
raw_author_name: Thao Nguyen
raw_affiliation_strings: Charité Universitätsmedizin - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Charitéplatz 1, 10117 Berlin, Germany
German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site Berlin 10117 Berlin, Germany
National Center of Tumor Diseases (NCT), Heidelberg, Germany
raw_author_name: Jakob Dannehl
raw_affiliation_strings: Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353 Berlin, Germany
German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site Berlin 10117 Berlin, Germany
National Center of Tumor Diseases (NCT), Heidelberg, Germany
raw_author_name: Celina Höhne
raw_affiliation_strings: Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353 Berlin, Germany
German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site Berlin 10117 Berlin, Germany
National Center of Tumor Diseases (NCT), Heidelberg, Germany
raw_author_name: Marcus Beck
raw_affiliation_strings: Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353 Berlin, Germany
German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site Berlin 10117 Berlin, Germany
National Center of Tumor Diseases (NCT), Heidelberg, Germany
raw_author_name: Julia Bauer
raw_affiliation_strings: Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353 Berlin, Germany
German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site Berlin 10117 Berlin, Germany
National Center of Tumor Diseases (NCT), Heidelberg, Germany
raw_author_name: Daniel Zips
raw_affiliation_strings: Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353 Berlin, Germany
German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site Berlin 10117 Berlin, Germany
National Center of Tumor Diseases (NCT), Heidelberg, Germany
raw_author_name: Carolin Senger
raw_affiliation_strings: Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, 13353 Berlin, Germany
German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site Berlin 10117 Berlin, Germany
National Center of Tumor Diseases (NCT), Heidelberg, Germany